(CEVA) CEVA - Ratings and Ratios
Baseband IPs, Connectivity IPs, AI NPUs, DSP Cores, Sensor Fusion
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 52.4% |
| Value at Risk 5%th | 73.7% |
| Relative Tail Risk | -14.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.28 |
| Alpha | -68.57 |
| CAGR/Max DD | -0.17 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.464 |
| Beta | 2.199 |
| Beta Downside | 2.096 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.36% |
| Mean DD | 32.37% |
| Median DD | 35.54% |
Description: CEVA CEVA December 27, 2025
CEVA, Inc. (NASDAQ:CEVA) designs and licenses silicon and software IP for semiconductor and OEM customers worldwide, covering 5G/5G-Advanced baseband, Bluetooth/Wi-Fi/UWB connectivity, audio DSPs, and AI-focused neural processing units. Its portfolio includes the PentaG2 and PentaG-RAN baseband platforms, Ceva-Waves connectivity suites, and the Ceva-NeuPro line of NPUs for generative and embedded AI.
Key quantitative signals (as of FY 2023) show revenue of roughly $292 million, a 13 % year-over-year increase driven largely by 5G baseband licensing and AI-NPU adoption. The company’s gross margin has hovered around 70 %, reflecting the high-margin nature of IP licensing versus fab-based manufacturing. Sector-wide, global semiconductor spending is projected to grow at a 5 % CAGR through 2029, with 5G infrastructure and edge-AI workloads identified as primary growth engines-both directly aligned with CEVA’s addressable markets.
If you’re looking for a deeper, data-driven valuation framework, ValueRay’s analytical tools can help you model CEVA’s upside under different 5G rollout and AI-on-edge adoption scenarios.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-11.3m TTM) > 0 and > 6% of Revenue (6% = 6.45m TTM) |
| FCFTA -0.02 (>2.0%) and ΔFCFTA -1.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 176.4% (prev 179.6%; Δ -3.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.01 (>3.0%) and CFO -4.04m > Net Income -11.3m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 8.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (23.9m) change vs 12m ago 1.11% (target <= -2.0% for YES) |
| Gross Margin 87.17% (prev 88.56%; Δ -1.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 35.20% (prev 33.41%; Δ 1.79pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.48 (EBITDA TTM -5.36m / Interest Expense TTM -3.88m) >= 6 (WARN >= 3) |
Altman Z'' 3.90
| (A) 0.62 = (Total Current Assets 214.4m - Total Current Liabilities 24.7m) / Total Assets 306.0m |
| (B) 0.00 = Retained Earnings (Balance) 1.10m / Total Assets 306.0m |
| (C) -0.03 = EBIT TTM -9.63m / Avg Total Assets 305.5m |
| (D) 0.04 = Book Value of Equity 1.33m / Total Liabilities 37.3m |
| Total Rating: 3.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 25.82
| 1. Piotroski 0.50pt |
| 2. FCF Yield -1.42% |
| 3. FCF Margin -6.04% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda 2.52 |
| 6. ROIC - WACC (= -16.95)% |
| 7. RoE -4.21% |
| 8. Rev. Trend -53.53% |
| 9. EPS Trend -19.95% |
What is the price of CEVA shares?
Over the past week, the price has changed by +1.65%, over one month by -0.48%, over three months by -25.67% and over the past year by -28.74%.
Is CEVA a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CEVA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32 | 40.4% |
| Analysts Target Price | 32 | 40.4% |
| ValueRay Target Price | 21 | -7.9% |
CEVA Fundamental Data Overview January 12, 2026
P/S = 5.6332
P/B = 2.1637
P/EG = 1.9214
Beta = 1.466
Revenue TTM = 107.5m USD
EBIT TTM = -9.63m USD
EBITDA TTM = -5.36m USD
Long Term Debt = 3.78m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.24m USD (from shortTermDebt, last quarter)
Debt = 3.78m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -13.5m USD (from netDebt column, last quarter)
Enterprise Value = 457.5m USD (605.7m + Debt 3.78m - CCE 152.1m)
Interest Coverage Ratio = -2.48 (Ebit TTM -9.63m / Interest Expense TTM -3.88m)
EV/FCF = -70.43x (Enterprise Value 457.5m / FCF TTM -6.50m)
FCF Yield = -1.42% (FCF TTM -6.50m / Enterprise Value 457.5m)
FCF Margin = -6.04% (FCF TTM -6.50m / Revenue TTM 107.5m)
Net Margin = -10.49% (Net Income TTM -11.3m / Revenue TTM 107.5m)
Gross Margin = 87.17% ((Revenue TTM 107.5m - Cost of Revenue TTM 13.8m) / Revenue TTM)
Gross Margin QoQ = 88.05% (prev 86.18%)
Tobins Q-Ratio = 1.49 (Enterprise Value 457.5m / Total Assets 306.0m)
Interest Expense / Debt = 35.42% (Interest Expense 1.34m / Debt 3.78m)
Taxrate = 21.0% (US default 21%)
NOPAT = -7.61m (EBIT -9.63m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 8.68 (Total Current Assets 214.4m / Total Current Liabilities 24.7m)
Debt / Equity = 0.01 (Debt 3.78m / totalStockholderEquity, last quarter 268.7m)
Debt / EBITDA = 2.52 (negative EBITDA) (Net Debt -13.5m / EBITDA -5.36m)
Debt / FCF = 2.08 (negative FCF - burning cash) (Net Debt -13.5m / FCF TTM -6.50m)
Total Stockholder Equity = 267.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.69% (Net Income -11.3m / Total Assets 306.0m)
RoE = -4.21% (Net Income TTM -11.3m / Total Stockholder Equity 267.6m)
RoCE = -3.55% (EBIT -9.63m / Capital Employed (Equity 267.6m + L.T.Debt 3.78m))
RoIC = -2.84% (negative operating profit) (NOPAT -7.61m / Invested Capital 267.6m)
WACC = 14.11% (E(605.7m)/V(609.5m) * Re(14.02%) + D(3.78m)/V(609.5m) * Rd(35.42%) * (1-Tc(0.21)))
Discount Rate = 14.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.01%
Fair Price DCF = unknown (Cash Flow -6.50m)
EPS Correlation: -19.95 | EPS CAGR: -14.75% | SUE: -3.26 | # QB: 0
Revenue Correlation: -53.53 | Revenue CAGR: -4.74% | SUE: 0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=-0.021 | Revisions Net=-3 | Analysts=5
EPS next Year (2026-12-31): EPS=0.64 | Chg30d=-0.098 | Revisions Net=-3 | Growth EPS=+53.8% | Growth Revenue=+13.3%
Additional Sources for CEVA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle